Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty's Government what assessment they have made of the case for early human challenge trials to assist with the development of a COVID-19 vaccine.
The Vaccine Taskforce fully recognises the importance of effective clinical trials to demonstrate the safety and efficacy of potential vaccines. The case for early human challenge studies is under constant review and we are working at pace to develop a vaccine as quickly as possible.